PharmiWeb.com - Global Pharma News & Resources

Biotech - Press Releases

Date Title Company
09-Sep-2024 VIVES IUF Fund raises additional €5M capital from Luxembourg Future Fund 2 Andrew Lloyd Associates
06-Sep-2024 Xinnate presents TCP-25 data at international dermatology congress Xinnate AB
06-Sep-2024 PureTech Founded Entity Vor Bio Announces New Clinical Data Validating Approach of Using Shielded Transplants to Deliver Targeted Therapies PureTech Health plc
06-Sep-2024 Asgard Therapeutics’ study published in Science showing proof-of-concept and strong anti-tumor responses via in vivo cell reprogramming with lead program AT-108 Asgard Therapeutics
06-Sep-2024 Realheart to Present Positive Results From Two Preclinical Studies Evaluating Treatment Safety of Its Total Artificial Heart at ISMCS 2024 Scandinavian Real Heart AB
06-Sep-2024 Crick Skylab opens as MSD commence new research programmes The Francis Crick Institute
06-Sep-2024 EDX MEDICAL APPOINTS CHIEF COMMERCIAL OFFICER EDX Medical Group plc
06-Sep-2024 European Commission Grants Orphan Drug Designation for Vivet Therapeutics Gene Therapy Product for the Treatment of Cerebrotendinous Xanthomatosis (CTX) Vivet Therapeutics
06-Sep-2024 Flex Databases - Top Clinical Trial Management Provider 2024 Flex Databases
05-Sep-2024 Integrated DNA Technologies Bolsters Comprehensive Genomic Profiling Solutions With Launch of New Archer™ HRD Technology for Cancer Research Integrated DNA Technologies
05-Sep-2024 Andrew MacGarvey & Conditor Capital Launch Coronado Research to maximise the use of data and technology in drug development; Dr Nicholas Edwards announced as Chair Coronado Research
05-Sep-2024 Ciliatech presents 36-month follow-up data on novel CID implant, Intercil® Uveal Spacer, for treating glaucoma Andrew Lloyd Associates
04-Sep-2024 Innovation Passport Award CRISM Therapeutics Corporation
04-Sep-2024 WHO’s mpox response plan provides direction for coordinated response to reduce disease burden, says GlobalData World Health Organization (WHO)
04-Sep-2024 Vesper Bio announces successful Phase I study for potentially disease-modifying treatment for frontotemporal dementia Vesper Bio
04-Sep-2024 Phesi wins Frost & Sullivan’s Global Enabling Technology Leadership Award for Revolutionizing Clinical Development with its Trial Accelerator Platform Phesi
04-Sep-2024 Kosten Digital Launches in the U.S. to Transform Life Sciences with Custom AI Solutions, Welcomes Industry Leader Amy DuRoss to Advisory Board Kosten Digital
04-Sep-2024 Russell Abberley, Amgen UK & Ireland, steps up as Acting ABPI President Association of the British Pharmaceutical Industry (ABPI)
04-Sep-2024 Envirotainer completes integration of va-Q-tec’s pharma business, advancing the future of pharma cold chain Envirotainer
04-Sep-2024 Vesper Bio announces successful Phase I study for potentially disease-modifying treatment for frontotemporal dementia Vesper Bio